GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PEPTONIC medical AB (XSAT:PMED) » Definitions » Sale Of Investment

PEPTONIC medical AB (XSAT:PMED) Sale Of Investment : kr0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is PEPTONIC medical AB Sale Of Investment?

PEPTONIC medical AB's sale of investment for the three months ended in Sep. 2024 was kr0.00 Mil. It means PEPTONIC medical AB gained kr0.00 Mil from selling investments. PEPTONIC medical AB's sale of investment for the trailing twelve months (TTM) ended in Sep. 2024 was kr0.00 Mil.

Compared with last quarter (kr0.00 Mil in Jun. 2024 ), PEPTONIC medical AB gained the same money from selling investments in Sep. 2024 (kr0.00 Mil).

PEPTONIC medical AB Sale Of Investment Historical Data

The historical data trend for PEPTONIC medical AB's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PEPTONIC medical AB Sale Of Investment Chart

PEPTONIC medical AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

PEPTONIC medical AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PEPTONIC medical AB Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PEPTONIC medical AB Sale Of Investment Related Terms

Thank you for viewing the detailed overview of PEPTONIC medical AB's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

PEPTONIC medical AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PEPTONIC medical AB (XSAT:PMED) » Definitions » Sale Of Investment
Comparable Companies
XSAT:ODI OSTO:VIVE XSAT:DICOT OSTO:ERMA OSTO:NANEXA OSTO:NEWBRY OSTO:KLAR OSTO:RLS OSTO:EMPLI OSTO:GABA ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
Gustavslundsvagen 143, Bromma, SWE, SE-167 51
Website
https://www.peptonicmedical.se
PEPTONIC medical AB is a pharmaceutical company. It is engaged in developing oxytocin-based products for the treatment of menopausal symptoms, such as vaginal atrophy and vaginal dryness. Oxytocin is for medical use and offers an alternative to estrogen and estrogen-like acting compounds for menopausal and postmenopausal women. The company is based in Sweden.

PEPTONIC medical AB Headlines

No Headlines